Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S(TSE:AMGN)
CA$34.46+0.17 (+0.50%)
TSE:AMGN
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S stock analysis
CA$34.46
At close:+0.17 (+0.50%)
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S (AMGN) Stock Price & Analysis
2 Followers
AMGN Stock Chart & Stats
CA$34.46CA$0.17(0.50%)
At close: 4:00 PM EST
- Day’s Range
- CAD 33.90 - CAD 34.47
- 52-Week Range
- CAD 23.95 - CAD 35.46
- Previous Close
- CAD 34.29
- Volume
- N/A
- Average Volume (3M)
- 3,724
- Market Cap
- CAD 358.61B
- Enterprise Value
- CAD 74.96B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 26.9
- Beta
- 1.12
- Next Earnings
- Feb 09, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Nov 20, 2026
- Dividend Yield
- 2.14%
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S News
AMGN FAQ
What was Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s price range in the past 12 months?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S lowest stock price was C$23.95 and its highest was C$35.46 in the past 12 months.
What is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s market cap?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s market cap is C$358.61B.
When is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s earnings last quarter?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S released its earnings results on Nov 03, 2026. The company reported C$9.907 earnings per share for the quarter.
Is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S pay dividends?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S pays a dividend of C$0.185 which represents an annual dividend yield of 2.14%. See more information on Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S dividends here
What is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s EPS estimate?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S have?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S has 540,911,500 shares outstanding.
What happened to Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s price movement after its last earnings report?
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S reported an EPS of C$9.907 in its last earnings report. Following the earnings report the stock price went up 3.344%.
Which hedge fund is a major shareholder of Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S?
Currently, no hedge funds are holding shares in TSE:AMGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
- Sector
- General
- Industry
- Drug Manufacturers - General
- CEO
- Robert A. Bradway
- Employees
- 31,500
- Website
- www.amgen.com
- Address
- One Amgen Center Drive, Thousand Oaks, CA, 91320-1799, US
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S (AMGN) Earnings & Revenues
AMGN Earnings Call
Q3 2026
Earnings Call SentimentPositive
The call was strongly positive. Amgen reported broad-based sales growth, strong performance from its key growth drivers, multiple positive late-stage clinical readouts, continued pipeline investment, and raised 2026 revenue and non-GAAP EPS guidance. The main negatives were TEPEZZA's 6% sales decline, expected fourth-quarter expense increases, higher projected other expense, and stated uncertainty around the symptomatic Sjogren's readout and market-access challenges. Highlights significantly outweighed lowlights.
View all TSE:AMGN earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 6 | 0 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 12 | 0 | 0 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| TSE:ROGRoche Holding Ltd CAD Hedged CIBC CDR | ||
| TSE:NVSNovartis AG CAD Hedged CIBC CDR | ||
| TSE:PFEPfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S | ||
| TSE:MRKMerck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S | ||
| TSE:GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S |
